David Levi Nathan, MD | |
8244 E Us Highway 36, Suite 1220, Avon, IN 46123-9613 | |
(317) 272-1366 | |
(317) 272-1388 |
Full Name | David Levi Nathan |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 31 Years |
Location | 8244 E Us Highway 36, Avon, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619963998 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 01051097 (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hendricks Regional Health | Danville, IN | Hospital |
Entity Name | Comprehensive Dermatology Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1689660946 PECOS PAC ID: 3577652718 Enrollment ID: O20071211000244 |
News Archive
A group of scientists, including one from the University of California, Riverside, have discovered a long-hypothesized male determining gene in the mosquito species that carries malaria, laying the groundwork for the development of strategies that could help control the disease.
Scientists have highlighted for the first time the plight of the growing number of older children and adolescents living with undiagnosed HIV and AIDS in Africa. In a study published today in Clinical Infectious Diseases, Wellcome Trust researchers claim that delay in recognising this problem means that the needs of this important group are not being met.
Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group) announce today that they have initiated the first-in-human clinical study of OBT357 (MEN1112), a novel enhanced antibody for the treatment of acute myeloid leukemia (AML).
In the event of a smallpox outbreak in the United States, how long would it take for a vaccine to start protecting Americans by stimulating an immune response? A new national study led by Saint Louis University School of Medicine will attempt to answer this question.
More than half a million people may have died last year as a result of reductions in TB diagnosis and care, setting back progress towards ending the disease by a decade, the World Health Organization (WHO) estimates.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
David Levi Nathan, MD 8244 E Us Highway 36, Suite 1220, Avon, IN 46123-9613 Ph: (317) 272-1366 | David Levi Nathan, MD 8244 E Us Highway 36, Suite 1220, Avon, IN 46123-9613 Ph: (317) 272-1366 |
News Archive
A group of scientists, including one from the University of California, Riverside, have discovered a long-hypothesized male determining gene in the mosquito species that carries malaria, laying the groundwork for the development of strategies that could help control the disease.
Scientists have highlighted for the first time the plight of the growing number of older children and adolescents living with undiagnosed HIV and AIDS in Africa. In a study published today in Clinical Infectious Diseases, Wellcome Trust researchers claim that delay in recognising this problem means that the needs of this important group are not being met.
Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group) announce today that they have initiated the first-in-human clinical study of OBT357 (MEN1112), a novel enhanced antibody for the treatment of acute myeloid leukemia (AML).
In the event of a smallpox outbreak in the United States, how long would it take for a vaccine to start protecting Americans by stimulating an immune response? A new national study led by Saint Louis University School of Medicine will attempt to answer this question.
More than half a million people may have died last year as a result of reductions in TB diagnosis and care, setting back progress towards ending the disease by a decade, the World Health Organization (WHO) estimates.
› Verified 5 days ago